Supplementary Table 1 from A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease

Abstract

<p>Clinicopathologic features stratified by treatment arm (RNA-seq analysis population).<b></b></p>